|Ampal-American Israel||Herzliya, Israel, Tel Aviv|
|DeltaPoint Capital Management||New York, Rochester, United States|
|Frontline BioVentures||China, Shanghai|
|Karel Electronics||Ankara, Ankara, Turkey|
|NorthPort Investments||Minnesota, Northfield, United States|
|Primecap Management||California, Pasadena, United States|
|Quester||England, London, United Kingdom|
|Scala Ventures||Lugano, Switzerland, Ticino|
|Snowball Effect||Auckland, New Zealand, Parnell|
|Tomita Pharmaceutical||Japan, Kumamoto, Kumamoto Prefecture|
|ZDNet||California, San Francisco, United States|
|Zheke Huifu Chuang Tou||China, Hangzhou, Zhejiang|
|$4M||30 Oct 2019||South Korea, Gyeonggi-do, South Korea|
|$4M||22 Jan 2019||Busan, Pusan-jikhalsi, South Korea|
|$2M||09 Jun 2018||South Korea|
|$12M||30 Mar 2018||South Korea, Gyeonggi-do, South Korea|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.